Company Monitoring Page for Abbott

job ratings for Abbott

03/23/17
industry:
Medical Device
company:
Abbott
job rating:
3
the most political organization i've ever worked for. great benefits, ok/middling work, extremely shockingly poor management
10/20/16
industry:
diagnostics
job title:
field service engineer
company:
Abbott
job rating:
1
horrible work conditions

latest headlines for company on cafepharma

Are Supply Chain Pressures Easing for Medtech?
Medical Devices and Diagnostics Industry
Thu, 02/2/23 - 10:45 am
Tags:
Medtech, supply chain, GE Healthcare, Stryker, Abbott, Boston Scientific, Intuitive Surgical
AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring
Fierce Pharma
Fri, 10/19/18 - 11:13 pm
Tags:
AbbVie, Abbott, Imbruvica
UPDATE: Abbott plans to close $5B Alere buyout next week
Mass Device
Sat, 09/30/17 - 10:17 am
Tags:
Abbott, Alere, M&A, devices
Abbott tangles with Indian regulators over cough syrup complaint
Yahoo/Reuters
Mon, 09/14/15 - 08:12 am
Tags:
India, Abbott, cough syrup, Phensedyl
Abbott to vote for Mylan's acquisition of Perrigo
Yahoo/Reuters
Tue, 06/16/15 - 12:03 pm
Tags:
Abbott, Mylan Labs, Perrigo, M&A
Abbott, AbbVie Win Dismissal of Suit Over Depakote Marketing
Bloomberg
Sat, 08/16/14 - 08:39 am
Tags:
Abbott, AbbVie, Depakote
Mylan to Buy Abbott’s Generic-Drug Unit, Cut Tax Rate
Bloomberg
Mon, 07/14/14 - 09:30 am
Tags:
Mylan, M&A, Abbott, generics, taxes
Abbott, AbbVie get to defend testosterone lawsuits on their own turf
Fierce Pharma
Mon, 06/9/14 - 11:28 am
Tags:
Abbott, AbbVie, testosterone, Androgel
Stent wars: Researchers report a tie, of sorts, for Medtronic’s Resolute and Abbott’s Xience V DES
Mass Device
Wed, 07/3/13 - 03:30 pm
Tags:
stent, research, Medtronic, devices, Abbott
Abbott Declares Dividend and $3 Billion Buyback Plan
The Motley Fool
Sun, 06/16/13 - 11:28 am
Tags:
Abbott, dividend, stock, stock buyback
Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold
Yahoo/PRNewswire
Tue, 06/11/13 - 10:28 pm
Tags:
Abbott, clinical trials, Japan, international, devices
Should Any Big Pharma Buy Bausch & Lomb?
Motley Fool
Thu, 01/10/13 - 09:48 am
Tags:
M&A, Bausch & Lomb, Pfizer, Sanofi, JNJ, Abbott, Merck
Will AbbVie's Drug Pipeline Cloud Its Growth Prospects?
Motley Fool
Wed, 01/9/13 - 10:01 am
Tags:
AbbVie, Abbott, Eli Lilly, Merck, Pfizer
Neurocrine Biosciences: Elagolix-Channel Checks And Expert Opinion Reveal Small Market Size, Unfavorable Incentives
Seeking Alpha
Mon, 01/7/13 - 01:03 pm
Tags:
Neurocrine Biosciences, Elagolix, Abbott, AbbVie
Abbott wins FDA approval for heart stent
Reuters
Thu, 01/3/13 - 03:17 pm
Tags:
Abbott, FDA, heart, stent, devices
Inside the New Abbott: A Lot Like the Old Abbott But Without Humira
Motley Fool
Fri, 12/21/12 - 10:16 am
Tags:
Abbott, AbbVie, Humira
Abbott board paves way for split of company
Reuters
Thu, 11/29/12 - 10:35 am
Tags:
Abbott, AbbVie
Abbott, Reata kidney disease drug trial stopped
Reuters
Thu, 10/18/12 - 11:42 am
Tags:
Abbott, Reata, kidney disease, Bardoxolone, AbbVie, Humira
New Indication for Abbott's Humira
Yahoo/Zacks
Fri, 10/5/12 - 11:20 am
Tags:
Abbott, Humira, ulcerative colitis
Abbott touts global launch of 1st-of-its-kind bioresorbable drug-eluting stent
Mass Device
Wed, 09/26/12 - 11:00 pm
Tags:
Abbott, international, stent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.